Updated:
IMS Health Inc.
IMS Health Inc., predecessor to IQVIA, operated as a healthcare data and analytics firm with petabytes of proprietary patient data. Based in Danbury, CT.
IMS Health Inc.
IMS Health Inc. was originally founded as a data and analytics provider to the pharmaceutical industry, amassing what the firm described as petabytes of proprietary data and non-identified patient records. Its headquarters was located in Danbury, Connecticut, United States. The company tracked a meaningful share of global pharmaceutical sales and operated in numerous countries, establishing a global footprint. The firm's business strategy centered on connecting data, technology, and human science to accelerate clinical development. IMS Health provided real-world evidence, market insights, and commercial execution solutions. Its expertise included faster clinical trial site identification and technology platforms tailored to healthcare. The firm's proprietary data assets and analytics served as a backbone for life sciences decision-making. In 2016, IMS Health merged with Quintiles to form IQVIA Holdings Inc., a publicly traded company (NYSE: IQV). The combined entity expanded its offerings to include clinical development services through IQVIA Biotech. IQVIA has since been named to Fortune's World's Most Admired Companies list multiple years (per Fortune, 2026) and partnered with NVIDIA in 2026 to accelerate Healthcare-grade AI (per firm announcement, 2026). The structural differentiator of IMS Health was its massive proprietary dataset covering non-identified patient records and global pharma sales, which created significant barriers to entry for competitors. This data moat, combined with analytics capabilities, made the firm a critical infrastructure provider rather than a pure consultancy.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Danbury
Corporate office
Danbury, United States
Frequently asked questions
What happened to IMS Health Inc.?
IMS Health Inc. merged with Quintiles in 2016 to form IQVIA Holdings Inc., a publicly traded company (NYSE: IQV). The combined entity operates as a provider of clinical research, data analytics, and technology services to the life sciences industry (per SEC filings, 2016).
Does IMS Health Inc. still exist as an independent firm?
No. IMS Health Inc. ceased to exist as an independent entity after its merger with Quintiles in 2016. Its operations and data assets are now part of IQVIA Holdings Inc., which continues to use the IMS Health brand for certain data products (per IQVIA website, 2026).
What data assets did IMS Health Inc. own?
IMS Health Inc. maintained what it described as petabytes of proprietary data, including non-identified patient records and tracking of a significant percentage of global pharmaceutical sales. This data was used for real-world evidence, market insights, and clinical trial optimization (per IMS Health website, archived).
Who were the key principals of IMS Health Inc.?
Publicly available sources during IMS Health Inc.'s independent existence did not prominently feature a single named principal or founder figure. The firm was led by a management team and reported to a board of directors. After the merger, Ari Bousbib became CEO of IQVIA (per IQVIA filings, 2016).
Was IMS Health Inc. a family office?
No. IMS Health Inc. was a publicly traded company prior to its acquisition by investment firms including TPG Capital and Canada Pension Plan Investment Board in 2009. It was never structured as a single family office or multi-family office (per SEC filings, 2009).
What sectors did IMS Health Inc. focus on?
IMS Health Inc. focused exclusively on the life sciences and healthcare sector, providing data, analytics, and technology services to pharmaceutical, biotech, and medical device companies. Its core vertical was pharmaceutical sales tracking and clinical development support (per IMS Health website, archived).
How is IMS Health Inc. related to IQVIA?
IMS Health Inc. and Quintiles merged in 2016 to create IQVIA Holdings Inc. IMS Health's data and analytics business became part of IQVIA's Technology & Analytics Solutions segment. The IMS Health brand continues to be used for certain data products under the IQVIA umbrella (per IQVIA website, 2026).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: